The jury of US district court in Oregon found that Arthrex is guilty of infringing US Patent 5,601,557, which is licensed to Smith & Nephew Endoscopy, a subsidiary of Smith & Nephew.
The jury found that Arthrex’s Bio-SutureTak, PEEK SutureTak, PushLock and Bio-PushLock suture anchors infringe the patent and awarded Smith & Nephew $85m for Arthrex’s past infringement activities.
The Bio-SutureTak is a 3 mm bioabsorbable ‘push-in’ suture anchor with a molded-in suture eyelet for soft tissue attachment to bone in the shoulder joint and other indications where a small anchor profile with high pull-out strength is required.
The PEEK SutureTak is a nonabsorbable suture anchor made of non-reactive thermoplastic material and benefits both metal alloy and bioabsorbable materials and is anchor alternative for labral instability repair of the shoulder.
The PushLock and Bio-PushLock sutures are knotless suture anchors designed for arthroscopic glenohumeral joint instability repair .
Smith & Nephew provides services in the field of Orthopaedics, including reconstruction, trauma and clinical therapies; endoscopy, including sports medicine; and advanced wound management.